Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
fFpMCeGT09gaMTKc
